Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF.

[1]  M. Simons,et al.  Translational physiology: porcine models of human coronary artery disease: implications for preclinical trials of therapeutic angiogenesis. , 2003, Journal of applied physiology.

[2]  Brian H Annex,et al.  The VIVA Trial Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis , 2003 .

[3]  I. Herman,et al.  Mechanisms of normal and tumor-derived angiogenesis. , 2002, American journal of physiology. Cell physiology.

[4]  R. Coleman,et al.  A comparison of mechanical and laser transmyocardial revascularization for induction of angiogenesis and arteriogenesis in chronically ischemic myocardium. , 2002, Journal of the American College of Cardiology.

[5]  T. Henry,et al.  Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2: Double-Blind, Randomized, Controlled Clinical Trial , 2002, Circulation.

[6]  R. Weisel,et al.  Angiogenesis by endothelial cell transplantation. , 2001, The Journal of thoracic and cardiovascular surgery.

[7]  R. Coleman,et al.  Is chronically dysfunctional yet viable myocardium distal to a severe coronary stenosis hypoperfused? , 2001, The Annals of thoracic surgery.

[8]  F. Sellke,et al.  Therapeutic angiogenesis in cardiology using protein formulations. , 2001, Cardiovascular research.

[9]  R. B. Johnson,et al.  Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia. , 2001, Journal of the American College of Cardiology.

[10]  R. Coleman,et al.  Induction of angiogenesis after TMR: a comparison of holmium: YAG, CO2, and excimer lasers. , 2000, The Annals of thoracic surgery.

[11]  R. Coleman,et al.  An experimental model of chronic myocardial hibernation. , 2000, The Annals of thoracic surgery.

[12]  J. Pearlman,et al.  Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia. , 2000, The Journal of pharmacology and experimental therapeutics.

[13]  A. Quyyumi,et al.  Intracoronary basic fibroblast growth factor enhances myocardial collateral perfusion in dogs. , 2000, Journal of the American College of Cardiology.

[14]  Simons,et al.  Therapeutic Angiogenesis Using Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor Using Various Delivery Strategies. , 1999, Current interventional cardiology reports.

[15]  F. Sellke,et al.  Intracoronary and intravenous administration of basic fibroblast growth factor: myocardial and tissue distribution. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[16]  J. Lowe,et al.  Transmyocardial laser revascularization: experimental and clinical results. , 1999, The Canadian journal of cardiology.

[17]  J. Lowe,et al.  Metabolic Changes in the Normal and Hypoxic Neonatal Myocardium , 1999, Annals of the New York Academy of Sciences.

[18]  R. Coleman,et al.  Neovascularization after transmyocardial laser revascularization in a model of chronic ischemia. , 1998, The Annals of thoracic surgery.

[19]  J. Pearlman,et al.  VEGF administration in chronic myocardial ischemia in pigs. , 1998, Cardiovascular research.

[20]  C. Degueldre,et al.  Relation between contractile reserve and positron emission tomographic patterns of perfusion and glucose utilization in chronic ischemic left ventricular dysfunction: implications for identification of myocardial viability. , 1997, Journal of the American College of Cardiology.

[21]  D. Dadhania,et al.  Pharmacodynamics of basic fibroblast growth factor: route of administration determines myocardial and systemic distribution. , 1997, Cardiovascular research.

[22]  E. Edelman,et al.  Basic fibroblast growth factor in a porcine model of chronic myocardial ischemia: a comparison of angiographic, echocardiographic and coronary flow parameters. , 1997, The Journal of pharmacology and experimental therapeutics.

[23]  S. Epstein,et al.  Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. , 1996, Circulation.

[24]  B. Keyt,et al.  VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. , 1996, The Journal of surgical research.

[25]  J. Pearlman,et al.  Vascular endothelial growth factor administration in chronic myocardial ischemia. , 1996, The American journal of physiology.

[26]  J. Pearlman,et al.  Magnetic resonance mapping demonstrates benefits of VEGF–induced myocardial angiogenesis , 1995, Nature Medicine.

[27]  W Grossman,et al.  Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. , 1994, The Journal of clinical investigation.

[28]  S. Epstein,et al.  Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. , 1994, Circulation.

[29]  S. Epstein,et al.  Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. , 1994, The American journal of physiology.

[30]  E. Brogi,et al.  Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. , 1994, The Journal of clinical investigation.

[31]  R. Roncucci,et al.  Preclinical and Clinical Studies with Recombinant Human Basic Fibroblast Growth Factor , 1991, Annals of the New York Academy of Sciences.

[32]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[33]  J. Lowe,et al.  [Transmyocardial laser revascularization]. , 1999, Zentralblatt fur Chirurgie.